Sclerosis News and Research

RSS

How Epstein-Barr virus shapes immune responses in multiple sclerosis

Study found that EBV-specific immune responses in MS patients showed higher IgG titers and cell-mediated reactions to EBV antigens compared to healthy controls, suggesting a complex role of EBV in MS development.

9 Jun 2024

Access to neurologist care linked to better ALS patient survival and quality of life

ALS patients received better care if they were treated by a neurologist, a new study published in PLOS One has found.

7 Jun 2024

Curcumin nanoparticles show promise in treating neurodegenerative diseases

Review demonstrates curcumin's neuroprotective effects in neurodegenerative diseases, enhancing its potential through innovative nanoparticle formulations. This advancement could significantly improve treatments for diseases like Parkinson's, Alzheimer's, and Multiple Sclerosis.

6 Jun 2024

New brain scan tool reveals key insights into childhood brain development

Study demonstrates that the OPM-MEG tool effectively tracks brain development and neural oscillations in individuals aged 2 to 34, offering new insights into neurological health and development.

6 Jun 2024

Does diet influence the onset of multiple sclerosis?

A recent study using the UK Biobank data indicates that a healthy diet, including moderate fatty fish and alcohol consumption, can reduce the risk of multiple sclerosis (MS) onset.

5 Jun 2024

Common drugs linked to reduced risk of bleeding stroke from brain aneurysm

A new study suggests that people who take a few common drugs may have a decreased risk of having a bleeding stroke due to a ruptured brain aneurysm.

5 Jun 2024

New report highlights the urgent need for increased investment in MS research

A new report has revealed the prolonged time to diagnose multiple sclerosis (MS) and highlighted the urgent need for increased investment in MS research and enhanced awareness of the disease.

3 Jun 2024

RCSI and Head Diagnostics collaborate to revolutionize multiple sclerosis assessment

RCSI has partnered with Head Diagnostics (Dublin, Ireland) on a clinical study to enhance the assessment and monitoring of Multiple Sclerosis (MS) through innovative technology.

30 May 2024

Delayed multiple sclerosis diagnosis underscores need for urgent research and awareness boost, report find

A new report from MS Australia reveals that the average time to diagnose multiple sclerosis is nearly four years, highlighting the urgent need for increased research investment and enhanced awareness.

29 May 2024

Self-reported memory problems and partner confirmation may signal tau buildup in the brain

People who report early memory problems and whose partners also suspect they have memory problems have higher levels of tau tangles in the brain, a biomarker associated with Alzheimer's disease, according to a study published in the May 29, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

29 May 2024

Study examines the effects of pregnant mother's epilepsy medications on child's creativity

While older drugs for epilepsy, taken while pregnant, have been shown in previous research to affect the creative thinking of children, a new study finds no effects on creativity for children born to those taking newer epilepsy drugs.

29 May 2024

New research highlights a promising approach to tackling for ALS

A recent collaborative research endeavor, published in the prestigious Cell Press journal Cell Reports Medicine, highlights a promising therapeutic avenue for amyotrophic lateral sclerosis (ALS).

29 May 2024

Understanding the link between EBV-infected B cells and multiple sclerosis

The Wistar Institute's Paul M. Lieberman, Ph.D., and lab team led by senior staff scientist and first author, Samantha Soldan, Ph.D., have demonstrated how B cells infected with the Epstein-Barr virus (EBV) can contribute to a pathogenic, inflammatory phenotype that contributes to multiple sclerosis (MS); the group has also shown how these problematic B cells can be selectively targeted in a way that reduces the damaging autoimmune response of multiple sclerosis.

28 May 2024

Phytochemicals show promise in treating neurological disorders by influencing the gut-brain axis

Researchers reviewed the potential therapeutic effects of phytochemicals on the gut-brain axis, finding they could influence brain function and reduce neurological symptoms by modulating gut microbiota.

26 May 2024

Experts recommend structured approach to optimize exercise interventions in MS rehabilitation

A team of experts in multiple sclerosis (MS) research recommends a structured approach to the study of mechanisms of exercise training for improving outcomes for multiple sclerosis (MS).

24 May 2024

Targeting metabolic pathways to combat Epstein-Barr virus infections

The Epstein-Barr virus can cause a spectrum of diseases, including a range of cancers.

24 May 2024

Revolutionizing neurological research: Barrow Neuro Analytics Center opens in Phoenix

Barrow Neurological Institute has opened a new cutting-edge research center that is expected to revolutionize neurological research and expand Phoenix's research footprint into the areas of environmental neurology and health equity.

24 May 2024

Study offers insights into factors influencing older adults to stop driving

What factors lead older adults to stop driving? A new study followed older adults who had no memory or thinking problems to examine this question.

23 May 2024

Higher intake of ultra-processed foods linked to increased risk of stroke and cognitive decline

People who eat more ultra-processed foods like soft drinks, chips and cookies may have a higher risk of having memory and thinking problems and having a stroke than those who eat fewer processed foods, according to a new study published in the May 22, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

22 May 2024

Eliminating race adjustment in lung function tests may alter diagnosis and disability eligibility

Removing race from equations that estimate lung function will shift the categorization of disease severity across patient populations, moving more Black individuals into an advanced disease category, according to new research led by scientists at Harvard Medical School.

20 May 2024

Sclerosis News and Research

How Epstein-Barr virus shapes immune responses in multiple sclerosis

Access to neurologist care linked to better ALS patient survival and quality of life

Curcumin nanoparticles show promise in treating neurodegenerative diseases

New brain scan tool reveals key insights into childhood brain development

Does diet influence the onset of multiple sclerosis?

Common drugs linked to reduced risk of bleeding stroke from brain aneurysm

New report highlights the urgent need for increased investment in MS research

RCSI and Head Diagnostics collaborate to revolutionize multiple sclerosis assessment

Delayed multiple sclerosis diagnosis underscores need for urgent research and awareness boost, report find

Self-reported memory problems and partner confirmation may signal tau buildup in the brain

Study examines the effects of pregnant mother's epilepsy medications on child's creativity

New research highlights a promising approach to tackling for ALS

Understanding the link between EBV-infected B cells and multiple sclerosis

Phytochemicals show promise in treating neurological disorders by influencing the gut-brain axis

Experts recommend structured approach to optimize exercise interventions in MS rehabilitation

Targeting metabolic pathways to combat Epstein-Barr virus infections

Revolutionizing neurological research: Barrow Neuro Analytics Center opens in Phoenix

Study offers insights into factors influencing older adults to stop driving

Higher intake of ultra-processed foods linked to increased risk of stroke and cognitive decline

Eliminating race adjustment in lung function tests may alter diagnosis and disability eligibility

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News